In arguably the most important therapeutic news of the pandemic since Dexamethasone, the RECOVERY trial investigators have revealed the initial results on the Tocilizumab arm of the trial showing a […]
JC: RECOVERY trial shows Tocilizumab effective for COVID19. St Emlyn’s Read More »
We have previously covered the RECOVERY trial on St Emlyn’s noting that the first results out of this large pragmatic, adaptive design platform RCT showed no benefit to Hydroxychloroquine. A
Dexamethasone, COVID-19 and the RECOVERY trial. St Emlyn’s Read More »
I remember back at the beginning of the pandemic when we were seeing lots of patients arriving in the ED in extremis. The now familiar picture of the deeply hypoxic
JC: Non-invasive ventilation for COVID 19 patients. The Recovery RS trial. St Emlyn’s Read More »
We’ve talked about the RECOVERY trial on the blog and podcast before. This is a UK based platform trial (more on this later) looking at patients admitted to hospital with
The RECOVERY platform trial: No benefit to Hydroxychloroquine in Covid-19. St Emlyn’s Read More »
Critical Appraisal of the The PATCH trial of TXA Tranexamic Acid in major trauma patients. TXA saves lives, but functional outcomes vary. #FOAMed @stemlyns
JC: The PATCH trial. TXA in major trauma. St Emlyn’s Read More »
This week JAMA published three important trials on the use of steroids in patients with severe COVID-19, with an additional cherry on top; a subsequent inclusive meta-analysis (totalling 7 RCTs
The ‘Roid’ to Recovery? REMAP-CAP @ St Emlyn’s Read More »
International Clinical Trials Day 2015 is on 20th May. To mark the occasion we’re going to run an extra special critical appraisal. This time, let’s look at an awesome piece
JC: An International Clinical Trials Day Special Read More »
St Emlyn’s Journal Club on the future of EBM with a twist. Really interesting article in Nature Medicine this month with implications for EM research. #FOAMed @stemlyns @VivekSubbiah
JC: The future of evidence based medicine. St Emlyn’s. Read More »
We’ve reported on the RECOVERY trial several times already on the blog. It stands out as the most important trial of therapeutics in hospitalised patients with COVID19. In the last
High dose vs. Low dose steroids in hospitalised COVID 19 patients. St Emlyn’s. Read More »
We’ve reported on the RECOVERY trial several times already on the blog. It stands out as the most important trial of therapeutics in hospitalised patients with COVID19. In the last
Baricitinib for hospitalised COVID19 patients. St Emlyn’s Read More »
